STAT April 24, 2024
Theresa Gaffney

Physicians, researchers, CEOs, reporters, and more gathered in downtown Boston Wednesday night to celebrate STAT’s 2024 STATUS List, which features 50 leaders in the life sciences. Members of this year’s list (and a few past list members) spoke about what issues in their fields — ranging from investment to clinical research to bedside treatment — need to be prioritized in order to improve health care across the U.S. and the rest of the world.

Equity and inclusion

Achieving true equity in medical science “requires us to divest our research from the ivory towers of elite institutions,” said 2023 list member Jonathan Jackson,...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Conferences / Podcast, Pharma / Biotech, Trends
Akiko Iwasaki: The Immunology of Covid and the Future
Novartis to acquire radiopharmaceutical firm Mariana Oncology for up to $1.75B
GLP-1 Agonists May One Day Treat Prostate Cancer
Amgen shares soar as executives outline obesity drug push
BridgeBio, Ipsen, George Medicines and more—Chutes & Ladders

Share This Article